The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature Reviews Immunology · doi:10.1038/nri3265 · Cited by 972
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850
Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 825
Aquaporin water channels in the nervous system
Papadopoulos, M. C., & Verkman, A. S. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3468 · Cited by 741
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., & Reindl, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022328 · Cited by 616
Plasma exchange for severe attacks of CNS demyelination: Predictors of response
Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M., & Weinshenker, B. G. (2002) · Neurology · doi:10.1212/wnl.58.1.143 · Cited by 600
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis
Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24117 · Cited by 518
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Hayter, S. M., & Cook, M. C. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.001 · Cited by 464
Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Stern, J. N. H., Yaari, G., Vander Heiden, J. A., Church, G., Donahue, W. F., Hintzen, R. Q., Huttner, A. J., Laman, J. D., Nagra, R. M., Nylander, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008879 · Cited by 441
Kitley, J., Leite, M. I., Nakashima, I., Waters, P., McNeillis, B., Brown, R., Takai, Y., Takahashi, T., Misu, T., Elsone, L., et al. (2012) · Brain · doi:10.1093/brain/aws109 · Cited by 438
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O'Connor, K. C., McLaughlin, K. A., De Jager, P. L., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar-Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 416
Self-citationBrunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J., & Linington, C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10930.x · Cited by 409
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Waters, P., Woodhall, M., O'Connor, K. C., Reindl, M., Lang, B., Sato, D. K., Juryńczyk, M., Tackley, G., Rocha, J., Takahashi, T., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000089 · Cited by 390
Neurofascin as a novel target for autoantibody-mediated axonal injury
Mathey, E. K., Derfuss, T., Storch, M. K., Williams, K. R., Hales, K., Woolley, D. R., Al-Hayani, A., Davies, S. N., Rasband, M. N., Olsson, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071053 · Cited by 390
Ramanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515593406 · Cited by 384
Self-citationThe spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Di Pauli, F., Rostásy, K., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 375
Schluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 371
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W., & Berger, T. (1999) · Brain · doi:10.1093/brain/122.11.2047 · Cited by 347
Bettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336
Krishnamoorthy, G., Lassmann, H., Wekerle, H., & Holz, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28330 · Cited by 335
GALLSTONE DISAPPEARANCE ASSOCIATED WITH WEIGHT LOSS
Thornton, J. R. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91537-x · Cited by 329
Brilot, F., Dale, R. C., Selter, R. C., Grummel, V., Reddy Kalluri, S., Aslam, M., Busch, V., Zhou, D., Cepok, S., & Hemmer, B. (2009) · Annals of Neurology · doi:10.1002/ana.21916 · Cited by 322
Self-citationA novel myelin-associated glycoprotein defined by a mouse monoclonal antibody
Linnington, C., Webb, M., & Woodhams, P. L. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90064-x · Cited by 321
Baumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., Mader, S., Karenfort, M., Selch, C., Hausler, M., Eisenkolbl, A., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308346 · Cited by 314
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Pröbstel, A. K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 306
Self-citationFailure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 294
Piddlesden, S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 287
Höftberger, R., Sepulveda, M., Armangue, T., Blanco, Y., Rostásy, K., Cobo Calvo, A., Olascoaga, J., Ramió-Torrentà, L., Reindl, M., Benito-León, J., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 285
Min, J.-H., Kim, B. J., & Lee, K. H. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511431973 · Cited by 280
Zamvil, S. S., & Slavin, A. J. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000062 · Cited by 276
Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
Prineas, J. W., & Graham, J. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100205 · Cited by 264
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M. S., Hartung, H.-P., Polman, C. H., Miller, D. H., Montalban, X., Barkhof, F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063602 · Cited by 255
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.085 · Cited by 249
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Jiao, Y., Fryer, J. P., Lennon, V. A., Jenkins, S. M., Quek, A. M. L., Smith, C. Y., McKeon, A., Costanzi, C., Iorio, R., Weinshenker, B. G., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cb5c · Cited by 244
Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
Gardinier, M. V., Amiguet, P., Linington, C., & Matthieu, J. ‐. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330123 · Cited by 244
Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J.-M., Gardinier, M. V., Dornmair, K., & Linington, C. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00124-7 · Cited by 232
Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.-P., Stadelmann, C., & Hemmer, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607242103 · Cited by 231
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
Ramanathan, S., Reddel, S. W., Henderson, A., Parratt, J. D. E., Barnett, M., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000040 · Cited by 231
Self-citationMyelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., Palace, J., Wassmer, E., Tardieu, M., Vincent, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000081 · Cited by 230
Linington, C., & Lassmann, H. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90031-2 · Cited by 221
Pham-Dinh, D., Mattei, M. G., Nussbaum, J. L., Roussel, G., Pontarotti, P., Roeckel, N., Mather, I. H., Artzt, K., Lindahl, K. F., & Dautigny, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7990 · Cited by 220
Jarius, S., Franciotta, D., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P. S., Reuss, R., Probst, C., Kristoferitsch, W., Wandinger, K. P., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-52 · Cited by 209
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
Di Pauli, F., Mader, S., Rostasy, K., Schanda, K., Bajer-Kornek, B., Ehling, R., Deisenhammer, F., Reindl, M., & Berger, T. (2011) · Clinical Immunology · doi:10.1016/j.clim.2010.11.013 · Cited by 200
Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
McLaughlin, K. A., Chitnis, T., Newcombe, J., Franz, B., Kennedy, J., McArdel, S., Kuhle, J., Kappos, L., Rostasy, K., Pohl, D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801888 · Cited by 189
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis
Rostasy, K., Mader, S., Schanda, K., Huppke, P., Gärtner, J., Kraus, V., Karenfort, M., Tibussek, D., Blaschek, A., Bajer-Kornek, B., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2956 · Cited by 182
Johns, T. G., Kerlero de Rosbo, N., Menon, K. K., Abo, S., Gonzales, M. F., & Bernard, C. C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5536 · Cited by 181
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
Ketelslegers, I. A., Van Pelt, D. E., Bryde, S., Neuteboom, R. F., Catsman-Berrevoets, C. E., Hamann, D., & Hintzen, R. Q. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566666 · Cited by 179
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
Spadaro, M., Gerdes, L. A., Mayer, M. C., Ertl-Wagner, B., Laurent, S., Krumbholz, M., Breithaupt, C., Högen, T., Straube, A., Giese, A., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.164 · Cited by 176
Lalive, P. H., Menge, T., Delarasse, C., Della Gaspera, B., Pham-Dinh, D., Villoslada, P., von Büdingen, H.-C., & Genain, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510672103 · Cited by 173
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Dale, R. C., Tantsis, E. M., Merheb, V., Kumaran, R.-Y. A., Sinmaz, N., Pathmanandavel, K., Ramanathan, S., Booth, D. R., Wienholt, L. A., Prelog, K., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000012 · Cited by 173
Self-citationIMMUNOGLOBULIN-CONTAINING CELLS IN MULTIPLE-SCLEROSIS PLAQUES
Esiri, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91603-8 · Cited by 171
Aquaporin-4 antibody–negative neuromyelitis optica: Distinct assay sensitivity–dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e917 · Cited by 170
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
Pröbstel, A.-K., Rudolf, G., Dornmair, K., Collongues, N., Chanson, J.-B., Sanderson, N. S., Lindberg, R. L., Kappos, L., de Seze, J., & Derfuss, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0256-1 · Cited by 169
Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
O’Connor, K. C., Appel, H., Bregoli, L., Call, M. E., Catz, I., Chan, J. A., Moore, N. H., Warren, K. G., Wong, S. J., Hafler, D. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1974 · Cited by 168
Lindert, R.-B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H., & Hohlfeld, R. (1999) · Brain · doi:10.1093/brain/122.11.2089 · Cited by 167
de Rosbo, N. K., Honegger, P., Lassmann, H., & Matthieu, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04173.x · Cited by 166
Rostasy, K. M., Mader, S., Hennes, E. M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512470310 · Cited by 163
Mayer, M. C., Breithaupt, C., Reindl, M., Schanda, K., Rostasy, K. M., Berger, T., Dale, R. C., Brilot, F., Olsson, T. P., Jenne, D. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301296 · Cited by 159
Self-citationSimilar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects
Lampasona, V., Franciotta, D. M., Furlan, R., Zanaboni, S., Fazio, R., Bonifacio, E. E., Comı, G., & Martino, G. (2004) · Neurology · doi:10.1212/01.wnl.0000127615.15768.ae · Cited by 157
Clinical and MRI phenotype of children with MOG antibodies
Fernandez-Carbonell, C., Vargas-Lowy, D., Musallam, A., Healy, B. C., McLaughlin, K., Wucherpfennig, K. W., & Chitnis, T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515587751 · Cited by 156
Marta, C. B., Oliver, A. R., Sweet, R. A., Pfeiffer, S. E., & Ruddle, N. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504979102 · Cited by 155
Autoimmune encephalitis: Recent updates and emerging challenges
Ramanathan, S., Mohammad, S. S., Brilot, F., & Dale, R. C. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.07.017 · Cited by 153
Self-citationBrain-Reactive Antibodies and Disease
Diamond, B., Honig, G., Mader, S., Brimberg, L., & Volpe, B. T. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075041 · Cited by 150
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
Saadoun, S., Waters, P. J., Owens, G. P., Bennett, J. L., Vincent, A. C., & Papadopoulos, M. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-35 · Cited by 143
Akaishi, T., Sato, D. K., Nakashima, I., Takeshita, T., Takahashi, T., Doi, H., Kurosawa, K., Kaneko, K., Kuroda, H., Nishiyama, S., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-310206 · Cited by 141
Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein
Breithaupt, C., Schubart, A., Zander, H., Skerra, A., Huber, R., Linington, C., & Jacob, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133443100 · Cited by 136
Winger, R. C., Koblinski, J. E., Kanda, T., Ransohoff, R. M., & Müller, W. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400700 · Cited by 129
Esiri, M. M. (1980) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1980.tb00199.x · Cited by 126
Martínez‐Hernández, E., Sepúlveda, M., Rostasy, K. M., Höftberger, R., Graus, F., Harvey, R. J., Saiz, A., & Dalmau, J. O. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3602 · Cited by 122
Haase, C. G., Guggenmos, J., Brehm, U., Andersson, M., Olsson, T. P., Reindl, M., Schneidewind, J. M., Zettl, U. K., Heidenreich, F., Berger, T., et al. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00462-8 · Cited by 121
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
Chalmoukou, K., Alexopoulos, H., Akrivou, S., Stathopoulos, P., Reindl, M., & Dalakas, M. C. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000131 · Cited by 119
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis
Egg, R., Reindl, M., Deisenhammer, F., Linington, C., & Berger, T. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700503 · Cited by 116
Immune cell trafficking from the brain maintains CNS immune tolerance.
Mohammad, M., Tsai, V., Ruitenberg, M., Hassanpour, M., Li, H., Hart, P., Breit, S., Sawchenko, P., & Brown, D. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71544 · Cited by 116
Brehm, U., Piddlesden, S. J., Gardinier, M. V., & Linington, C. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00010-7 · Cited by 113
Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention
Damoiseaux, J. G. M. C., Andrade, L. E. C., Fritzler, M. J., & Shoenfeld, Y. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.01.017 · Cited by 108
NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA
Kruer, M. C., Koch, T., BOURDETTE, D. N., Chabas, D., Waubant, E. L., Mueller, S. G., Moscarello, M. A., Dalmau, J. O., Woltjer, R. L., & Adamus, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a7f · Cited by 104
von Büdingen, H. ‐., Hauser, S. L., Ouallet, J., Tanuma, N., Menge, T., & Genain, C. P. (2004) · European Journal of Immunology · doi:10.1002/eji.200425050 · Cited by 103
NMDA receptor antibodies associated with distinct white matter syndromes
Hacohen, Y., Absoud, M., Hemingway, C. A., Jacobson, L. W., Lin, J., Pike, M., Pullaperuma, S., Siddiqui, A. U., Wassmer, E., Waters, P. J., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000002 · Cited by 102
Karni, A., Bakimer-Kleiner, R., Abramsky, O., & Ben‐Nun, A. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.311 · Cited by 99
von Büdingen, H. ‐., Hauser, S. L., Fuhrmann, A., Nabavi, C. B., Lee, J. I., & Genain, C. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122092499 · Cited by 96
Cobo‐Calvo, Á., Sepúlveda, M., Bernard‐Valnet, R., Ruiz, A., Brassat, D., Martínez‐Yélamos, S., Saiz, A., & Marignier, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515591071 · Cited by 91
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis
Lim, E. T., Berger, T., Reindl, M., Dalton, C. M., Fernando, K., Keir, G., Thompson, E. J., Miller, D. H., & Giovannoni, G. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1187sr · Cited by 91
Lalive, P. H., Häusler, M., Maurey, H., Mikaeloff, Y., Tardieu, M., Wiendl, H., Schroeter, M., Hp, H., Kieseier, B., & Menge, T. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510389220 · Cited by 86
Hacohen, Y., Absoud, M., Woodhall, M. R., Cummins, C., Goede, C. G. E. L. D., Hemingway, C. A., Jardine, P. E., Kneen, R., Pike, M. G., Whitehouse, W. P., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306411 · Cited by 78
MOG antibody-associated diseases
Reindl, M., & Rostasy, K. M. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000060 · Cited by 76
Jarius, S., Wandinger, K.-P., Borowski, K., Stoecker, W., & Wildemann, B. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.10.048 · Cited by 73
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
Tomassini, V., Giglio, L. D., Reindl, M., Russo, P., Pestalozza, I. F., Pantano, P., Berger, T., & Pozzilli, C. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077622 · Cited by 71
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
Lolli, F., Rovero, P., Chelli, M., & Papini, A. M. (2005) · Neurology · doi:10.1212/wnl.65.5.781-b · Cited by 71
Relationship Between NMO-Antibody and Anti–MOG Antibody in Optic Neuritis
Kezuka, T., Usui, Y., Yamakawa, N., Matsunaga, Y., Matsuda, R., Masuda, M., Utsumi, H., Tanaka, K., & Gotô, H. (2011) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e31823c9b6c · Cited by 69
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
Gaertner, S., de Graaf, K. L., Greve, B., & Weissert, R. (2004) · Neurology · doi:10.1212/01.wnl.0000147259.34163.33 · Cited by 68
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults
Wang, H., Munger, K. L., Reindl, M., O’Reilly, É., Levin, L. I., Berger, T., & Ascherio, A. (2008) · Neurology · doi:10.1212/01.wnl.0000316195.52001.e1 · Cited by 67
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system
Tanaka, M., & Tanaka, K. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.03.001 · Cited by 62
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
Rauer, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.077784 · Cited by 61
Shao, H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0554 · Cited by 60
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
Kühle, J., Lindberg, R. L. P., Regeniter, A., Mehling, M., Hoffmann, F., Reindl, M., Berger, T., Radue, E. W., Leppert, D., & Kappos, L. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0299-4 · Cited by 59
Sakuma, H. (2004) · Brain · doi:10.1093/brain/awh260 · Cited by 59
Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases
Selter, R., Brilot, F., Grummel, V., Kraus, V., Cepok, S., Dale, R. C., & Hemmer, B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04096 · Cited by 58
Self-citationAntimyelin Antibodies with No Progression to Multiple Sclerosis
Pelayo, R., Tintoré, M., Montalbán, X., Rovira, À., Espejo, C., Reindl, M., & Berger, T. (2007) · New England Journal of Medicine · doi:10.1056/nejmc062467 · Cited by 57
Sinmaz, N., Amatoury, M., Merheb, V., Ramanathan, S., Dale, R. C., & Brilot, F. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12764 · Cited by 54
Self-citationIchikawa, M., Johns, T. G., Liu, J., & Bernard, C. C. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.919 · Cited by 47
Characterization and Expression of the cDNA Coding for the Human Myelin/Oligodendrocyte Glycoprotein
Pham-Dinh, D., Allinquant, B., Ruberg, M., Gaspera, B. D., Nussbaum, J. L., & Dautigny, A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062353.x · Cited by 45
Pittock, S., Reindl, M., Achenbach, S. J., Berger, T., Brück, W., König, F., Morales, Y., Lassmann, H., Bryant, S. C., Moore, S., et al. (2007) · Multiple Sclerosis · doi:10.1177/1352458506072189 · Cited by 45
Breithaupt, C., Schäfer, B., Pellkofer, H., Huber, R., Linington, C., & Jacob, U. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1255 · Cited by 43
Freedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., Keir, G., Öhman, S., Racke, M. K., Sharief, M., Sindic, C. J. M., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.865 · Cited by 41
Mathey, E. K., Breithaupt, C., Schubart, A., & Linington, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200425291 · Cited by 39
Menge, T., Lalive, P. H., von Büdingen, H. ‐., & Genain, C. P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-161 · Cited by 39
Khalil, M., Reindl, M., Lutterotti, A., Kuenz, B., Ehling, R., Gneiss, C., Lackner, P., Deisenhammer, F., & Berger, T. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.012 · Cited by 38
Hino‐Fukuyo, N., Haginoya, K., Nakashima, I., Sato, D. K., Takahashi, T., Misu, T., Fujihara, K., Hirose, M., Kakisaka, Y., Uematsu, M., et al. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.02.006 · Cited by 38
Saini, H., Rifkin, R. A., Gorelik, M., Huang, H., Ferguson, Z., Jones, M., & Levy, M. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-104 · Cited by 34
Menge, T., von Büdingen, H. ‐., Lalive, P. H., & Genain, C. P. (2007) · European Journal of Immunology · doi:10.1002/eji.200737249 · Cited by 33
Autoantigen Conformation Influences Both B- and T-cell Responses and Encephalitogenicity
de Graaf, K. L., Albert, M., & Weissert, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304246 · Cited by 24
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis
Reder, A. T., & Oger, J. J.-F. (2004) · Neurology · doi:10.1212/01.wnl.0000130069.55343.06 · Cited by 19
Bansal, P., Khan, T., Bussmeyer, U., Challa, D. K., Swiercz, R., Velmurugan, R., Ober, R. J., & Ward, E. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300019 · Cited by 17
Soares, R. M. G., Dias, A. T., de Castro, S. B. R., Alves, C. C. D. S., Evangelista, M. G., da Silva, L. C., Farias, R. E., Castañon, M. C. M. N., Juliano, M. A., & Ferreira, A. P. (2013) · Autoimmunity · doi:10.3109/08916934.2013.796938 · Cited by 15
Ohtani, S., Kohyama, K., & Matsumoto, Y. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01131.x · Cited by 13
Ngono, A. E., Lepetit, M., Reindl, M., Garcia, A., Guillot, F., Genty, A., Chesneau, M., Salou, M., Michel, L., Lefrère, F., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/673503 · Cited by 7
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
Ramanathan, S., Reddel, S., Henderson, A. P. D., Parratt, J. D. E., Barnett, M. H., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.065 · Cited by 3
Self-citation
Cited by
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R. C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H. J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1144-2 · Cited by 747
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ogawa, R., Nakashima, I., Takahashi, T., Kaneko, K., Akaishi, T., Takai, Y., Sato, D. K., Nishiyama, S., Misu, T., Kuroda, H., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000322 · Cited by 436
López-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J.-M., Chen, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1814 · Cited by 410
Metadata
- Authors
- Ramanathan, S., Dale, R. C., & Brilot, F.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 15
- Issue
- 4
- Pages
- 307-324
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2206286096
- Cited by
- 281
- References
- 135
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.